TL;DR
A suspected GLP-1 overdose needs case-specific advice, even if symptoms are mild. Call 911 for severe symptoms. In the U.S., call Poison Control at 1-800-222-1222 or visit poison.org after a confirmed or possible dosing error. Do not take your next dose until Poison Control or a clinician provides a plan.
GLP-1 overdose: what to do right now

Do not wait for severe symptoms before seeking advice. A dosing error might involve a duplicate dose, the wrong pen, an outdated syringe mark, or uncertainty about a vial’s concentration.
Do not induce vomiting or take another medicine to counteract the dose unless a clinician directs you to do so.
Gather the following:
- Pen, vial, or injector
- Syringe and its packaging
- Medication carton
- Prescription label
- Written dosing instructions
- List of other medicines
Give the care team accurate information, regardless of where the medication came from. There is no reason to let embarrassment delay care.
Call 911 for these emergency signs
Call 911 for trouble breathing, fainting, seizure, severe confusion, inability to wake, or other life-threatening symptoms. Do not drive if you feel faint, confused, or seriously ill. Ask someone to stay with you while help arrives.
Call Poison Control now for a suspected dosing error
In the U.S., call 1-800-222-1222 or use poison.org. Share the drug, possible amount, timing, symptoms, health conditions, and other medicines.
Do not delay the call while trying to calculate the exact dose. Explain what you know and identify anything uncertain. Outside the U.S., contact your local poison center or emergency service.
GLP-1 overdose symptoms and when they become serious
Possible GLP-1 overdose symptoms include nausea, vomiting, diarrhea, stomach pain, and reduced appetite. After an excessive dose, these effects may become more intense or persistent.
Risk depends on the dose, symptoms, fluid intake, urine output, existing conditions, and other medicines. Ongoing vomiting or diarrhea can lead to dehydration and may put stress on the kidneys.
Our guide to GLP-1 side effects and symptom triage explains how symptoms can affect routine dose and refill decisions.
Symptoms that need urgent medical advice
Seek urgent advice for:
- Repeated vomiting or inability to keep fluids down
- Little or no urine
- Marked dizziness or faintness
- Fast heartbeat with worsening weakness
- Severe or persistent abdominal pain
- Symptoms that continue to worsen
Call 911 for confusion, seizure, trouble breathing, loss of consciousness, or inability to wake.
Expected side effect or overdose warning sign
Mild nausea alone does not confirm an overdose. However, familiar side effects should not be dismissed when they are severe, persistent, or associated with a dosing error.
The amount injected, product strength, concentration, and injection time all matter—even if no symptoms have appeared.
Semaglutide and tirzepatide overdose

Semaglutide products include Ozempic and Wegovy, while tirzepatide products include Mounjaro and Zepbound. Errors may involve duplicate doses, the wrong pen strength, an outdated syringe mark, or confusion between vial concentrations.
These medicines are long-acting, so symptoms may not resolve quickly. There is no single threshold that defines an overdose in every case.
Semaglutide overdose versus expected side effects
Excess semaglutide may cause significant digestive symptoms and dehydration. Low blood sugar may also be a concern when it is taken with insulin or certain diabetes medicines.
Report the exact product, prescribed dose, suspected amount, injection time, and any other diabetes treatments.
Tirzepatide overdose versus expected side effects
Excess tirzepatide can present with similar stomach and fluid-loss concerns. Clearly state the medication name when seeking help because semaglutide and tirzepatide are not interchangeable.
Old instructions may no longer be safe after a change in pen strength or vial concentration. Our guides to tirzepatide 5 mg and tirzepatide 15 mg explain why we recommend dose-specific instructions and refill reviews.
Other GLP-1 drugs
Other GLP-1 medicines include liraglutide and dulaglutide. Their dosing schedules may differ, affecting monitoring and next-dose decisions. Poison Control or a clinician should provide the plan after an error.
Severe complications after a GLP-1 dosing error
Digestive symptoms can occur during GLP-1 treatment, but certain patterns require prompt assessment. Risk may be greater with dehydration, kidney disease, insulin, or sulfonylureas. Do not try to diagnose a complication at home.
Dehydration and kidney injury
Repeated vomiting, inability to drink, reduced urine, faintness, confusion, or worsening weakness may signal serious dehydration. Seek urgent advice rather than waiting for symptoms to become severe.
Low blood sugar with insulin or sulfonylureas
Possible low blood sugar symptoms include sweating, shaking, hunger, blurred vision, weakness, confusion, seizure, or loss of consciousness.
Check glucose if this will not delay emergency care. Tell the care team about insulin, sulfonylureas, and any other diabetes medicines. Call 911 for seizure, unconsciousness, inability to wake, or severe confusion.
Pancreatitis and gallbladder warning signs
Seek prompt assessment for severe or persistent upper abdominal pain, pain extending to the back, repeated vomiting, fever, yellowing of the skin or eyes, or right-sided upper abdominal pain. These symptoms need clinical evaluation.
How milligrams, milliliters, and syringe units differ
Milligrams measure drug mass. Milliliters measure liquid volume. Syringe units are volume markings on a particular syringe.
On a U-100 insulin syringe, 100 units equals 1 mL. It does not equal 100 mg. Likewise, 50 units is 0.5 mL—not 0.5 mg.
The calculation is:
Milligrams injected = concentration in mg/mL × volume in mL
Do not repeat or correct a dose until the pharmacy, prescriber, or Poison Control confirms the concentration and syringe type.
Why one syringe-unit chart can cause harm
The same syringe mark can deliver different milligram amounts from vials with different concentrations. A chart from another clinic, website, pharmacy, or older vial may not apply to the current product.
A label-based calculation example
This example explains the math; it is not a dosing recommendation.
For a vial labeled 2 mg/mL, a volume of 0.25 mL contains:
2 mg/mL × 0.25 mL = 0.5 mg
If the label is unclear, contact the dispensing pharmacy or prescriber. If the dose has already been injected, call Poison Control.
Pens, multi-dose vials, and compounded GLP-1 errors
Fixed-dose pens remove some measuring steps, but someone can still select the wrong strength or inject twice. Multi-dose vial errors may involve the wrong syringe, a misplaced decimal, confusion between units and milligrams, or outdated directions.
Compounded products may have different concentrations. A product name or total vial amount does not show what each syringe mark delivers. Our compounded tirzepatide safety and dosing guide covers the checks we recommend before a refill or product change.
What clear vial instructions should show
Instructions should identify:
- Prescribed dose in milligrams
- Concentration in milligrams per milliliter
- Injection volume in milliliters
- Correct mark for the supplied syringe
Patients should not have to assemble a dosing plan from conflicting labels.
What to do when the label and prescription appear to conflict
Do not guess or average the numbers. Photograph the vial, carton, syringe packaging, prescription label, and written directions. Contact the pharmacy or prescriber. If an uncertain dose was already injected, call Poison Control.
What to tell Poison Control, the prescriber, or the emergency team
Use the printed wording from the label whenever possible. Say clearly when an amount is only an estimate.
Medication details to collect
Report:
- Drug and product name
- Pen strength or vial concentration
- Prescribed dose
- Syringe type and mark used
- Estimated liquid volume
- Number and timing of injections
Patient and symptom details to collect
Report current symptoms, when they began, relevant health conditions, other medicines, and a blood glucose reading if available. Mention insulin, sulfonylureas, kidney disease, diabetes, or pancreas and gallbladder conditions. Keep the packaging available.
Monitoring and the next scheduled GLP-1 dose
Do not automatically take the next scheduled dose. Poison Control, the prescriber, or the treating clinician should decide when treatment can resume.
The plan will depend on the medicine, suspected amount, timing, symptoms, and other treatments. At usetemi.com, we recommend resolving unclear instructions before using the next refill dose.
Keep a simple record of vomiting, fluids, urine output, pain, glucose readings, and any new or worsening symptoms.
Do not rely on wait and see alone
Symptoms can worsen as fluid loss builds. Even without symptoms, a large or uncertain dose warrants professional advice.
How to prevent another dosing error
Keep only current instructions with the medicine. Record each injection, dose, concentration, volume, and syringe mark. Use the syringe confirmed by the pharmacy, and recheck directions whenever the product or concentration changes.
GLP-1 overdose questions
Can you overdose on a GLP-1 drug?
Yes. An excessive dose may cause severe or prolonged side effects. Call Poison Control for case-specific advice.
What if I took two weekly doses?
Record the strength and time of both injections, then call Poison Control or the prescriber. Do not take another dose without professional instructions.
What if I do not know how many milligrams I injected?
Collect the vial concentration, syringe type, syringe mark, and label photos. Avoid generic conversion charts.
How long can symptoms last?
Duration varies by medicine, amount, health conditions, symptoms, and other treatments. Ask a clinician how long monitoring should continue.
Should I skip my next dose?
Do not apply a fixed online rule. Wait for a case-specific plan from Poison Control or your clinician.
FAQ
Is mild nausea after an extra GLP-1 dose an emergency?
Mild nausea alone may not be an emergency, but the dosing error still needs review. Call Poison Control and report the product, strength, amount, and timing.
What should I do if I used 50 units instead of 5?
Call Poison Control and keep the vial and syringe nearby. The concentration is needed to determine the milligram amount. Do not take another dose.
Can I drink water while waiting for advice?
If you are alert, can swallow safely, and are not vomiting repeatedly, small amounts may be reasonable. Do not force fluids or delay seeking advice.
What if I took insulin with the GLP-1 drug?
Tell Poison Control or the emergency team. Check glucose if doing so will not delay care, and call 911 for severe confusion, seizure, unconsciousness, or inability to wake.
Can I take my next weekly dose if I feel normal?
Not automatically. Ask Poison Control or your clinician to set the next dose date based on the medication and circumstances.
Get clear instructions before your next dose
If the immediate danger has passed but your next dose remains unclear, contact your prescriber or use usetemi.com to request a medication review. Have the vial, label, syringe details, and injection record ready so our clinicians can help establish one clear dosing plan.




